New Data Uncover Potential of Expedited Pathway for Immunotherapy Development Through CAR Monocytes

May 15, 2020

Carisma Therapeutics expands on foundational first-of-its-kind engineered macrophage cell therapy platform study and explores time-reducing isolation-to-infusion pathway. For full press release, click here